Essentials im atopischen Ekzem-Management

 

 Permissions and Reprints

Zusammenfassung

Das insbesondere im Kindesalter sehr häufige atopische Ekzem benötigt eine stadiengerechte Ekzembehandlung unter besonderer Berücksichtigung der Basistherapie. Für die antientzündliche läsionale Behandlung stellen topische Steroide der 4. Generation sowie topische Calcineurin-Inhibitoren die Substanzen der Wahl dar. Das konsequente Meiden irritativer Faktoren sowie nach entsprechender Testung allergischer Provokationsfaktoren flankiert die therapeutischen Maßnahmen.

Abstract

Atopic eczema is a frequent chronic disease manifestating especially in early childhood. A disease-related anti-inflammatory treatment in combination with adjuvant basic therapy is mandatory. Topical 4^th generation steroids and topical calcineurin-inhibitors are the anti-inflammatory substances of choice. The consequent avoidance of irritatative and individual allergic provocation factors based on appropiate testing support active dermatological treatment.

Literatur

• 1 Abeck D. Topische Calcineurin-Inhibitoren bei atopischem Ekzem - Contra.  DMW. 2006;  131 1615
  PubMedGoogle Scholar
• 2 http://www.atopa.de/atopa_studie.htm
• 3 Baker B S. The role of microorganisms in atopic dermatitis.  Clin Exp Dermatol. 2006;  144 1-9
  CrossrefPubMedGoogle Scholar
• 4 Byremo S, Rod G, Carlsen K H. Effect of climate change in children with atopic eczema.  Allergy. 2006;  61 1403-1410
  CrossrefPubMedGoogle Scholar
• 5 Gauger A, Fischer S, Mempel M, Schaefer T, Foelster-Holst R, Abeck D, Ring J. Efficacy and functionality of silver-coated textiles in patients with atopic dermatitis.  J Eur Acad Dermatol Venereol. 2006;  20 534-541
  CrossrefPubMedGoogle Scholar
• 6 Heine G, Schnuch A, Uter W, Worm M. Type IV-sensitization profile of individuals with atopic eczema: results from the Information Network of Departements of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG).  Allergy. 2006;  61 611-616
  CrossrefPubMedGoogle Scholar
• 7 Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, Wahn U. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.  J Allergy Clin Immunol. 2004;  113 925-931
  CrossrefPubMedGoogle Scholar
• 8 Langer K, Breuer K, Kapp A, Werfel T. Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis.  Exp Dermatol. 2007;  16 124-129
  CrossrefPubMedGoogle Scholar
• 9 Senti G, Steinmann L S, Fischer B, Kurmann R, Storni T, Johansen P, Schmid-Grendelmeier P, Wüthrich B, Kundig T M. Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical steroid treatment.  Dermatology. 2006;  213 228-233
  CrossrefPubMedGoogle Scholar
• 10 Simpson E L. Atopic dermatitis prevention.  Dermatol Ther. 2006;  19 108-117
  CrossrefPubMedGoogle Scholar
• 11 Werfel T, Bruer K, Rueff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitisation to house dust mites: a multi-centre, randomised, dose-response study.  Allergy. 2006;  61 202-205
  CrossrefPubMedGoogle Scholar
• 12 Williams J R, Burr M L, Williams H C. Factors influencing atopic dermatitis - a questionnaire survey of schoolchildren’s perceptions.  Br J Dermatol. 2004;  150 1154-1161
  CrossrefPubMedGoogle Scholar
• 13 Wohlrab J, Jost G, Abeck D. Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis.  Skin Pharmacol Physiol. 2006;  20 71-76
  PubMedGoogle Scholar
• 14 Wollenberg A. Topische Calcineurin-Inhibitoren bei atopischem Ekzem - Pro.  DMW. 2006;  131 1614
  PubMedGoogle Scholar

Prof. Dr. med. Dietrich Abeck

Bergmannstraße 7
80339 München

Email: professorabeck@dermatologie-kompetenz.de